Here’s our Shoulder Stem Cells 2013 registry data for shoulders treated with the Regenexx-SD procedure using the patient’s own stem cells. This is a mix of patients with rotator cuff tears, arthritis, labral tears, and instability. It also includes some cases from the RegenexxNetwork. Note that we’re reporting up to two year data (we have a few cases at three years, but not enough to report yet). The shoulder patients are doing well. Based on our data review, rotator cuff tear patients are doing the best in the group. This is a procedure that involves very precise targeting of the stem cells into the tears using guidance. As a result, we are still recruiting for our randomized controlled trial using stem cell injections to treat shoulder rotator cuff tears.
The upshot? You won’t see this data elsewhere, especially with two year reporting. Our commitment to data transparency and publishing is what sets Regenexx apart.